Adult Cardiac Late Breaker

Unless otherwise noted, speakers have nothing to disclose.

Moderators

Marvin Atkins, Jr., MD

Brent Keeling, MD
Disclosure: AngioDynamics, Inc.: Advisory Board (Ongoing), Consultant (Ongoing); Penumbra, Inc.: Advisory Board (Ongoing)

Presentations

  1. Long Term Outcomes and Anticoagulation Practice in Mitral Valve Surgery – A Report from the STS Database
    Thomas A. Schwann, MD, MBA
     
  2. Surgical Management and Mechanical Circulatory Support in High-Risk Pulmonary Embolisms: Historical Context, Current Status, and Future Directions: A Scientific Statement From the American Heart Association
    Joshua Goldberg, MD
     
  3. ACC/AHA 2022 Guideline on the Management of Aortic Disease
    Ourania Preventza, MD, MBA
    Disclosure: Aortic Terumo: Consultant (Ongoing); W. L. Gore & Associates: Consultant (Ongoing)
     
  4. Pivotal Trial: Zone 2 TEVAR with Branched Endograft for Type B Aortic Dissection
    Nimesh D. Desai, MD, PhD
    Disclosure: Medtronic: Speaker (Terminated, November 2, 2021); Baxter: Consultant (Ongoing), Speaker (Ongoing); Terumo Aortic: Speaker (Terminated, September 9, 2022); W. L. Gore & Associates: Speaker (Terminated, July 1, 2022)
Activity summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
Activity opens: 
02/01/2023
Activity expires: 
02/01/2026
Cost:
$0.00
Part of: 
2023 STS Annual Meeting Online: Adult Cardiac Track
Rating: 
0

Available Credit

  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Price

Cost:
$0.00
Please login or register to take this course.

Unless otherwise noted, speakers have nothing to disclose.

Moderators

Marvin Atkins, Jr., MD

Brent Keeling, MD
Disclosure: AngioDynamics, Inc.: Advisory Board (Ongoing), Consultant (Ongoing); Penumbra, Inc.: Advisory Board (Ongoing)

Presentations

  1. Long Term Outcomes and Anticoagulation Practice in Mitral Valve Surgery – A Report from the STS Database
    Thomas A. Schwann, MD, MBA
     
  2. Surgical Management and Mechanical Circulatory Support in High-Risk Pulmonary Embolisms: Historical Context, Current Status, and Future Directions: A Scientific Statement From the American Heart Association
    Joshua Goldberg, MD
     
  3. ACC/AHA 2022 Guideline on the Management of Aortic Disease
    Ourania Preventza, MD, MBA
    Disclosure: Aortic Terumo: Consultant (Ongoing); W. L. Gore & Associates: Consultant (Ongoing)
     
  4. Pivotal Trial: Zone 2 TEVAR with Branched Endograft for Type B Aortic Dissection
    Nimesh D. Desai, MD, PhD
    Disclosure: Medtronic: Speaker (Terminated, November 2, 2021); Baxter: Consultant (Ongoing), Speaker (Ongoing); Terumo Aortic: Speaker (Terminated, September 9, 2022); W. L. Gore & Associates: Speaker (Terminated, July 1, 2022)